Tailoring Treatments with AI: Insights from Sanofi’s Shameer Khader

Shameer Khader from Sanofi delves into the transformative role of AI in healthcare, emphasizing a future where tailored treatments and human-AI hybrid interactions coexist harmoniously.

In a recent interview at Machinecon USA 2023, Shameer Khader, a leader from the biopharmaceutical company Sanofi, delved into the transformative role of artificial intelligence (AI) in the realm of healthcare and pharmaceuticals. His insights provide a glimpse into the future of patient-centric treatments and the harmonious integration of AI in healthcare.

Chasing the Miracles of Science with AI

Sanofi, as Khader describes, is a company dedicated to “chasing the miracles of science.” They harness the power of data, AI, machine intelligence, and the invaluable data from clinical trials and experiments. Khader leads the computational biology cluster within Sanofi, a part of the precision medicine function. The primary goal of precision medicine is to develop treatments tailored to individual patients.

Khader highlighted a significant challenge in healthcare: even the most successful medicines might only be effective for 30-40% of patients. The pressing questions are: Who are these responders? Who are the non-responders? Can data help identify them? Can therapies be developed specifically targeting these subsets? These are the challenges that Sanofi aims to address using a suite of technologies, including AI, large language models, and generative AI.

The Future of AI in Healthcare: A Hybrid Approach

A common concern in the integration of AI in healthcare is the potential loss of human touch. Will there be reduced human interaction in healthcare and the pharmaceutical industry due to AI?

Khader believes in a future where AI and human interactions coexist harmoniously. He envisions a “hybrid relationship” where the future of AI, especially in healthcare, is a combination of man and machine. Contrary to the fear of losing the human touch, Khader argues that AI can enhance human interactions. For instance, if a doctor can currently see 10 patients, with the aid of AI, they might be able to see 20 or 30. While AI can automate paperwork and certain interactions, the core element of human interaction remains intact.

In conclusion, Shameer Khader’s insights at Machinecon USA 2023 offer a promising vision of the future of healthcare. He emphasizes the potential of AI to tailor treatments to individual patients, ensuring more effective and personalized care. However, he also stresses the importance of maintaining a balance between AI-driven processes and human interactions, ensuring that the essence of care remains human-centric.

CDO Vision Dubai

26th October, 2023 | TAJ JUMEIRAH LAKES TOWERS | Dubai

Unite with Dubai's foremost Chief Data Officers at an exclusive networking event brought to you by AIM Leaders Council.

Our Latest Reports on Artificial Intelligence & Data Science

  • State of Global Capability Centers (GCCs) in India 2023

    The “GCC in India 2023” report offers a comprehensive examination of the rapidly evolving landscape of Global Capability Centers (GCCs) in India. It explores the different types of centers, including their functionalities and operational aspects. As businesses globally aim to centralize specific functions for better efficiency, India continues to be a preferred destination due to its talent pool and cost advantages.

  • Data Science Skills Study 2023

    In an era defined by the data revolution, the field of data analytics has become the backbone of decision-making across industries. As organizations strive to harness the power of data, the role of data and analytics professionals has evolved into one of paramount importance. The “Data Science Skill Study 2023” by AIM-Research delves into the multifaceted landscape of these professionals, shedding light on their skills, preferences, and the ever-evolving trends that shape their work.

  • Tackling the major roadblocks of text-based GenAI

    In recent years, the field of text-based generative artificial intelligence (AI) has witnessed remarkable advancements, revolutionizing natural language processing and generating human-like textual content. These AI models, such as GPT-3, have demonstrated unprecedented capabilities in generating coherent stories, answering questions, and even simulating human conversation.

    However, within this realm of immense promise, lie substantial challenges and obstacles that demand prudent navigation. As text-based generative AI achieves unprecedented capabilities, it simultaneously encounters complex roadblocks that necessitate careful consideration. These challenges encompass a range of intricate issues that span from accuracy and coherence to ethical considerations and contextual understanding.

    This report aims to explore and dissect the major roadblocks encountered in the domain of text-based generative AI and present effective strategies to overcome them.


  • Generative AI Tools: A Comprehensive Market Analysis

    The market for Generative AI tools is thriving, propelled by the expanding applications of these technologies and the growing recognition of their potential benefits. Industries across the spectrum, from tech and entertainment to healthcare and finance, are leveraging these tools to streamline processes, enhance creativity, and make strides in innovation.

    This report aims to provide an exhaustive analysis of Generative AI tools that are dedicated to individual functionalities. By investigating the market dynamics, uncovering trends, and identifying key players, this report offers essential insights into the current scenario and future prospects of these tools.


Subscribe to our Newsletter

By clicking the “Continue” button, you are agreeing to the AIM Terms of Use and Privacy Policy.

Supercharge your top goals and objectives to reach new heights of success!